Octreotide for left ventricular assist device-related gastrointestinal hemorrhage: Can we stop the bleeding?

ASAIO Journal

Volumn 59, Issue 4, 2013, Pages 450-451

  Rennyson, Stephen L ^a   Shah, Keyur B ^a   Tang, Daniel G ^a   Kasirajan, Vigneshwar ^a   Pedram, Sammy ^a   Cahoon, William ^a   Malhotra, Rajiv ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

arteriovenous; bleeding; gastrointestinal; left ventricular support device; LVAD; malformations; octreotide

Indexed keywords

ARTERIOVENOUS; BLEEDING; GASTROINTESTINAL; LVAD; MALFORMATIONS; OCTREOTIDE; SUPPORT DEVICES;

BIOMATERIALS; BIOPHYSICS;

LEFT VENTRICULAR ASSIST DEVICES;

ACETYLSALICYLIC ACID; CONJUGATED ESTROGEN; HEMOGLOBIN; HIRULOG; INOTROPIC AGENT; MISOPROSTOL; OCTREOTIDE; WARFARIN;

ADULT; ANTICOAGULANT THERAPY; ARTERIOVENOUS MALFORMATION; ARTICLE; BLOOD CELL COUNT; BLOOD TRANSFUSION; CAPSULE ENDOSCOPY; CASE REPORT; COMORBIDITY; CONGESTIVE HEART FAILURE; DIZZINESS; DRUG FORMULATION; FATIGUE; GASTROINTESTINAL DISEASE; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HORMONE SUBSTITUTION; HUMAN; INTERNATIONAL NORMALIZED RATIO; LEFT VENTRICULAR ASSIST DEVICE; LOW DRUG DOSE; MALE; MELENA; NONISCHEMIC CARDIOMYOPATHY; PEPTIC ULCER; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

GASTROINTESTINAL AGENTS; GASTROINTESTINAL HEMORRHAGE; HEART FAILURE; HEART-ASSIST DEVICES; HUMANS; MALE; MIDDLE AGED; OCTREOTIDE;

EID: 84881051850     PISSN: 10582916     EISSN: 1538943X     Source Type: Journal    
DOI: 10.1097/MAT.0b013e318295232d     Document Type: Article

References (8)

1. Aggarwal A, Pant R, Kumar S, et al: Incidence and management of gastrointestinal bleeding with continuous flow assist devices. Ann Thorac Surg 93: 1534-1540, 2012.
2. J ohn R, Lee S: The biological basis of thrombosis and bleeding in patients with ventricular assist devices. J Cardiovasc Transl Res 2: 63-70, 2009.
3. Slaughter MS: Hematologic effects of continuous flow left ventricular assist devices. J Cardiovasc Transl Res 3: 618-624, 2010.
4. Scarpignato C, Pelosini I: Somatostatin for upper gastrointestinal hemorrhage and pancreatic surgery. A review of its pharmacology and safety. Digestion 60 (suppl 3): 1-16, 1999.
5. Szilagyi A, Ghali MP: Pharmacological therapy of vascular malformations of the gastrointestinal tract. Can J Gastroenterol 20: 171-178, 2006.
6. Krikis N, Tziomalos K, Perifanis V, et al: Treatment of recurrent gastrointestinal haemorrhage in a patient with von Willebrand's disease with octreotide LAR and propranolol. Gut 54: 171-172, 2005.
7. Bowers M, McNulty O, Mayne E: Octreotide in the treatment of gastrointestinal bleeding caused by angiodysplasia in two patients with von Willebrand's disease. Br J Haematol 108: 524-527, 2000.
8. N ardone G, Rocco A, Balzano T, Budillon G: The efficacy of octreotide therapy in chronic bleeding due to vascular abnormalities of the gastrointestinal tract. Aliment Pharmacol Ther 13: 1429-1436, 1999.